Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Pharmacology and social media: Potentials and biases of web forums for drug mention analysis-case study of France.

Audeh B, Calvier FE, Bellet F, Beyens MN, Pariente A, Lillo-Le Louet A, Bousquet C.

Health Informatics J. 2019 Sep 30:1460458219865128. doi: 10.1177/1460458219865128. [Epub ahead of print]

PMID:
31566468
2.

Secondary stroke prevention: a population-based cohort study on anticoagulation and antiplatelet treatments, and the risk of death or recurrence.

Faure M, Castilloux AM, Lillo-Le-Louet A, Bégaud B, Moride Y.

Clin Pharmacol Ther. 2019 Sep 10. doi: 10.1002/cpt.1625. [Epub ahead of print]

PMID:
31502245
3.

Qualitative and Quantitative Analysis of Web Forums for Adverse Events Detection: "Strontium Ranelate" Case Study.

Karapetiantz P, Audeh B, Faille J, Lillo-Le Louët A, Bousquet C.

Stud Health Technol Inform. 2019 Aug 21;264:964-968. doi: 10.3233/SHTI190367.

PMID:
31438067
4.

An Iconic Approach to the Browsing of Medical Terminologies.

Lamy JB, Thuy VB, Lillo-Le Louët A, Bousquet C.

Stud Health Technol Inform. 2019 Aug 21;264:213-217. doi: 10.3233/SHTI190214.

PMID:
31437916
5.

Initial Experiments for Pharmacovigilance Analysis in Social Media Using Summaries of Product Characteristics.

Campillos-Llanos L, Grouin C, Lillo-Le Louët A, Zweigenbaum P.

Stud Health Technol Inform. 2019 Aug 21;264:60-64. doi: 10.3233/SHTI190183.

PMID:
31437885
6.

[Informativity of French web forums for the evaluation of side effects of baclofen].

Karapetiantz P, Lillo-Le Louët A, Bousquet C.

Therapie. 2019 May 31. pii: S0040-5957(19)30096-4. doi: 10.1016/j.therap.2019.05.003. [Epub ahead of print] French.

PMID:
31253414
7.

Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study.

Clement O, Dewachter P, Mouton-Faivre C, Nevoret C, Guilloux L, Bloch Morot E, Katsahian S, Laroche D; investigators of the CIRTACI study, Audebert M, Benabes-Jezraoui B, Benoit Y, Beot S, Berard F, Berthezene Y, Bertrand P, Bouffard J, Bourrain JL, Boyer B, Carette MF, Caron-Poitreau C, Cavestri B, Cercueil JP, Charpin DA, Collet E, Crombe-Ternamian A, Dalmas J, Decoux E, Defrance MF, Delaval Y, Demoly P, Depriester C, Depriester P, Didier A, Drouet M, Dupas B, Dupre-Goetchebeur D, Dzviga C, Fabre C, Ferretti G, Fourre-Jullian C, Girardin P, Giron J, Gouitaa M, Grenier N, Guenard Bilbault L, Guez S, Gunera-Saad N, Heautot JF, Herbin D, Hoarau C, Jacquot C, Julien C, Laborie L, Lambert C, Larroche P, Leclerc X, Lemaitre L, Leynadier F, Lillo-Le-Louet A, Louvel JP, Louvier N, Lucas MM, Meites G, Mennesson N, Metge L, Meunier Y, Monnier-Cholley L, Musacchio M, Nicolie B, Occelli G, Oesterle H, Paisant-Thouveny F, Panuel M, Railhac N, Rety-Jacob F, Rochefort-Morel C, Roy C, Sarlieve P, Sesay M, Sgro C, Taourel P, Terrier P, Theissen O, Topenot I, Valfrey J, Veillon F, Vergnaud MC, Veyret C, Vincent D, Wallaert B, Wessel F, Zins M.

EClinicalMedicine. 2018 Jul 28;1:51-61. doi: 10.1016/j.eclinm.2018.07.002. eCollection 2018 Jul.

8.

The Adverse Drug Reactions From Patient Reports in Social Media Project: Protocol for an Evaluation Against a Gold Standard.

Arnoux-Guenegou A, Girardeau Y, Chen X, Deldossi M, Aboukhamis R, Faviez C, Dahamna B, Karapetiantz P, Guillemin-Lanne S, Lillo-Le Louët A, Texier N, Burgun A, Katsahian S.

JMIR Res Protoc. 2019 May 7;8(5):e11448. doi: 10.2196/11448.

9.

Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.

Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A, Pontoizeau C, Cochat P, Bataille P, Bridoux F, Brignon P, Choquenet C, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Frimat M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M; French Cystinuria Group.

BJU Int. 2019 Feb 24. doi: 10.1111/bju.14721. [Epub ahead of print]

PMID:
30801923
10.

Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project".

Bousquet C, Audeh B, Bellet F, Lillo-Le Louët A.

Drug Saf. 2018 Dec;41(12):1371-1373. doi: 10.1007/s40264-018-0747-y. No abstract available.

PMID:
30341678
11.

Priapism in sickle cell disease: Beware of neuroleptics.

Quint R, Lillo-Le Louet A, Pouchot J, Arlet JB.

Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25156. [Epub ahead of print] No abstract available.

12.

Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate.

Chen X, Faviez C, Schuck S, Lillo-Le-Louët A, Texier N, Dahamna B, Huot C, Foulquié P, Pereira S, Leroux V, Karapetiantz P, Guenegou-Arnoux A, Katsahian S, Bousquet C, Burgun A.

Front Pharmacol. 2018 May 24;9:541. doi: 10.3389/fphar.2018.00541. eCollection 2018.

13.

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions.

Karapetiantz P, Bellet F, Audeh B, Lardon J, Leprovost D, Aboukhamis R, Morlane-Hondère F, Grouin C, Burgun A, Katsahian S, Jaulent MC, Beyens MN, Lillo-Le Louët A, Bousquet C.

Front Pharmacol. 2018 May 1;9:439. doi: 10.3389/fphar.2018.00439. eCollection 2018.

14.

Signal Detection for Baclofen in Web Forums: A Preliminary Study.

Karapetiantz P, Audeh B, Lillo-Le Louët A, Bousquet C.

Stud Health Technol Inform. 2018;247:421-425.

PMID:
29677995
15.

Usefulness of initial plasma dabigatran concentration to predict rebound after reversal.

Gendron N, Gay J, Lemoine M, Gaussem P, Lillo-Le-Louet A, Smadja DM.

Haematologica. 2018 May;103(5):e226-e229. doi: 10.3324/haematol.2017.183400. Epub 2018 Feb 22. No abstract available.

16.

Mining Adverse Drug Reactions in Social Media with Named Entity Recognition and Semantic Methods.

Chen X, Deldossi M, Aboukhamis R, Faviez C, Dahamna B, Karapetiantz P, Guenegou-Arnoux A, Girardeau Y, Guillemin-Lanne S, Lillo-Le-Louët A, Texier N, Burgun A, Katsahian S.

Stud Health Technol Inform. 2017;245:322-326.

PMID:
29295108
17.

Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.

Le Meur L, Tantet C, Lê MP, Desselas E, Bonnal C, Lillo-Le-Louet A, Sonneville R, Massias L, Giraud J, Descamps D, Yazdanpanah Y, Lariven S, Peytavin G.

J Antimicrob Chemother. 2018 Apr 1;73(4):1108-1110. doi: 10.1093/jac/dkx495. No abstract available.

PMID:
29294026
18.

The Adverse Drug Reactions from Patient Reports in Social Media Project: Five Major Challenges to Overcome to Operationalize Analysis and Efficiently Support Pharmacovigilance Process.

Bousquet C, Dahamna B, Guillemin-Lanne S, Darmoni SJ, Faviez C, Huot C, Katsahian S, Leroux V, Pereira S, Richard C, Schück S, Souvignet J, Lillo-Le Louët A, Texier N.

JMIR Res Protoc. 2017 Sep 21;6(9):e179. doi: 10.2196/resprot.6463.

19.

Real-world use of idarucizumab for dabigatran reversal in three cases of serious bleeding.

Gendron N, Feral-Pierssens AL, Jurcisin I, de Raucourt E, Bouton V, Fischer AM, Lorenceau-Savale C, Lillo-Le Louët A, Smadja DM.

Clin Case Rep. 2017 Feb 10;5(3):346-350. doi: 10.1002/ccr3.839. eCollection 2017 Mar.

20.

Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies.

Koutkias VG, Lillo-Le Louët A, Jaulent MC.

Expert Opin Drug Saf. 2017 Feb;16(2):113-124. doi: 10.1080/14740338.2017.1257604. Epub 2016 Dec 1.

PMID:
27813420
21.

[Automated grouping of terms associated to cardiac valve fibrosis in MedDRA].

Asfari H, Souvignet J, Lillo-Le Louët A, Trombert B, Jaulent MC, Bousquet C.

Therapie. 2016 Dec;71(6):541-552. doi: 10.1016/j.therap.2016.06.003. Epub 2016 Jul 21. French.

PMID:
27692980
22.

Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database.

Trinh-Duc A, Lillo-Le Louët A, Tellier E, Viard T, Le Gal G, Smadja DM.

Thromb Res. 2016 Oct;146:43-45. doi: 10.1016/j.thromres.2016.08.014. Epub 2016 Aug 24. No abstract available.

PMID:
27579488
23.

[Treatments with immunoglobulin and thrombotic adverse events].

Darnige L, Lillo-Le Louët A.

Rev Med Interne. 2014 Jan;35(1):39-44. doi: 10.1016/j.revmed.2013.07.006. Epub 2013 Sep 4. Review. French.

PMID:
24011913
24.

[Hemorrhagic accidents of the new oral anticoagulants and coagulation assays].

Samama MM, Conard J, Lillo-Le Louët A.

J Mal Vasc. 2013 Jul;38(4):259-70. doi: 10.1016/j.jmv.2013.05.005. Epub 2013 Jun 20. French.

PMID:
23790307
25.

[Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].

Huguet G, Lillo-Le Louet A, Darnige L, Loo H, Krebs MO.

Encephale. 2013 May;39 Suppl 1:S42-8. doi: 10.1016/j.encep.2013.02.003. Epub 2013 Apr 1. French.

PMID:
23557674
26.

[Drug-induced fever: a diagnosis to remember].

Vodovar D, Le Beller C, Lillo-Le-Louet A, Hanslik T, Megarbane B.

Rev Med Interne. 2014 Mar;35(3):183-8. doi: 10.1016/j.revmed.2013.02.023. Epub 2013 Mar 11. Review. French.

PMID:
23490338
27.

[Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin].

Chouchana L, Languille E, Weiss N, Billaud EM, Lillo-Le Louet A.

Presse Med. 2013 May;42(5):908-11. doi: 10.1016/j.lpm.2012.07.026. Epub 2012 Oct 12. French. No abstract available.

PMID:
23069229
28.

Drug Fever: a descriptive cohort study from the French national pharmacovigilance database.

Vodovar D, LeBeller C, Mégarbane B, Lillo-Le-Louet A, Hanslik T.

Drug Saf. 2012 Sep 1;35(9):759-67. doi: 10.2165/11630640-000000000-00000.

PMID:
22830618
29.

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.

Lillo-Le Louët A, Wolf M, Soufir L, Galbois A, Dumenil AS, Offenstadt G, Samama MM.

Thromb Haemost. 2012 Sep;108(3):583-5. doi: 10.1160/TH12-03-0149. Epub 2012 Jul 10. No abstract available.

PMID:
22782645
30.

Transfusions, major bleeding, and prevention of venous thromboembolism with enoxaparin or fondaparinux in thoracic surgery.

Girard P, Demaria J, Lillo-Le Louët A, Caliandro R, Le Guillou JL, Crespin M, de Sanctis A, Stern JB.

Thromb Haemost. 2011 Dec;106(6):1109-16. doi: 10.1160/TH11-06-0433. Epub 2011 Oct 20.

PMID:
22012244
31.

Anaphylactic reaction after methylene blue-treated plasma transfusion.

Dewachter P, Castro S, Nicaise-Roland P, Chollet-Martin S, Le Beller C, Lillo-le-Louet A, Mouton-Faivre C.

Br J Anaesth. 2011 May;106(5):687-9. doi: 10.1093/bja/aer009. Epub 2011 Feb 9.

32.

A qualitative approach to signal mining in pharmacovigilance using formal concept analysis.

Lillo-Le Louët A, Toussaint Y, Villerd J.

Stud Health Technol Inform. 2010;160(Pt 2):969-73.

PMID:
20841828
33.

Documentation in pharmacovigilance: using an ontology to extend and normalize Pubmed queries.

Delamarre D, Lillo-Le Louët A, Guillot L, Jamet A, Sadou E, Ouazine T, Burgun A, Jaulent MC.

Stud Health Technol Inform. 2010;160(Pt 1):518-22.

PMID:
20841741
34.

Valganciclovir prophylaxis for cytomegalovirus infection in thoracic transplant patients: retrospective study of efficacy, safety, and drug exposure.

Lefeuvre S, Chevalier P, Charpentier C, Zekkour R, Havard L, Benammar M, Amrein C, Boussaud V, Lillo-Le Louët A, Guillemain R, Billaud EM.

Transpl Infect Dis. 2010 Jun;12(3):213-9. doi: 10.1111/j.1399-3062.2010.00491.x. Epub 2010 Jan 20.

PMID:
20102551
35.

A knowledge management platform for documentation of case reports in pharmacovigilance.

Amardeilh F, Bousquet C, Guillemin-Lanne S, Wiss-Thebault M, Guillot L, Delamarre D, Lillo-Le Louet A, Burgun A.

Stud Health Technol Inform. 2009;150:517-21.

PMID:
19745365
36.

Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.

Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM.

Transpl Infect Dis. 2009 Jun;11(3):211-9. doi: 10.1111/j.1399-3062.2009.00384.x. Epub 2009 Mar 17.

PMID:
19302272
37.

Comment on the editorial by M. Wybier entitled: "Transforaminal epidural corticosteroid injections and spinal cord infarction".

Le Beller C, Lillo-Le Louët A.

Joint Bone Spine. 2009 Jan;76(1):120; author reply 121-2. doi: 10.1016/j.jbspin.2008.10.004. Epub 2008 Dec 16. No abstract available.

PMID:
19091623
38.

Thalidomide-induced pneumonitis.

Wyplosz B, Lerolle U, Israël-Biet D, Dougados J, Lillo-Le Louët A, Ghez D, Pouchot J.

Eur J Intern Med. 2008 Nov;19(7):e57-8. doi: 10.1016/j.ejim.2008.02.004. Epub 2008 Apr 18. No abstract available.

PMID:
19013366
39.

[Fixed drug eruption caused by iodixanol].

Le Beller C, Fraitag S, Jacquot C, Lillo-Le Louët A, Auffret N.

Ann Dermatol Venereol. 2008 Oct;135(10):684-5. doi: 10.1016/j.annder.2008.05.006. Epub 2008 Jul 24. French. No abstract available.

PMID:
18929921
40.

Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.

Boussaud V, Daudet N, Billaud EM, Lillo-Le Louet A, Chevalier P, Amrein C, Bergé MM, Guillemain R, Le Beller C.

J Heart Lung Transplant. 2008 Feb;27(2):229-32. doi: 10.1016/j.healun.2007.09.022.

PMID:
18267232
41.

Off-label prescribing in a French hospital.

Cras A, Conscience MA, Rajzbaum G, Lillo-Le Louët A, Lopez N, Tersen I, Bezie Y.

Pharm World Sci. 2007 Apr;29(2):97-100. Epub 2006 Dec 12.

PMID:
17160629
42.

Recurrent iodide mumps after repeated administration of contrast media.

Wyplosz B, Scotté F, Lillo-Le Louët A, Chevrot A.

Ann Intern Med. 2006 Jul 18;145(2):155-6. No abstract available.

PMID:
16847303
43.

[A review of potential signals generated by an automated method on 3324 pharmacovigilance case reports].

Bousquet C, Sadakhom C, Le Beller C, Jaulen MC, Lillo-Le Louët A.

Therapie. 2006 Jan-Feb;61(1):39-47. Review. French.

PMID:
16792153
44.

Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone.

Wyplosz B, Vautier S, Lillo-Le Louët A, Capron L.

Br J Clin Pharmacol. 2006 Apr;61(4):474. No abstract available.

45.

Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.

Henegar C, Bousquet C, Lillo-Le Louët A, Degoulet P, Jaulent MC.

Comput Biol Med. 2006 Jul-Aug;36(7-8):748-67. Epub 2005 Sep 26.

PMID:
16185681
46.

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Jullien V, Tréluyer JM, Rey E, Jaffray P, Krivine A, Moachon L, Lillo-Le Louet A, Lescoat A, Dupin N, Salmon D, Pons G, Urien S.

Antimicrob Agents Chemother. 2005 Aug;49(8):3361-6. Erratum in: Antimicrob Agents Chemother. 2008 Feb;52(2):808.

47.

Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.

Bousquet C, Lagier G, Lillo-Le Louët A, Le Beller C, Venot A, Jaulent MC.

Drug Saf. 2005;28(1):19-34.

PMID:
15649103
48.

Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass.

Lillo-Le Louët A, Boutouyrie P, Alhenc-Gelas M, Le Beller C, Gautier I, Aiach M, Lasne D.

J Thromb Haemost. 2004 Nov;2(11):1882-8.

49.

A knowledge based approach for automated signal generation in pharmacovigilance.

Henegar C, Bousquet C, Lillo-Le Louët A, Degoulet P, Jaulent MC.

Stud Health Technol Inform. 2004;107(Pt 1):626-30.

PMID:
15360888
50.

[Hepatotoxicity of mizolastine (Mizollen) : report of 2 cases].

Jegou-Roux N, Chiffoleau A, Tiab M, Le Beller C, Guinnepain MT, Lillo-Le Louet A, Bourin M, Jolliet P.

Gastroenterol Clin Biol. 2001 Dec;25(12):1115-6. French. No abstract available.

Supplemental Content

Loading ...
Support Center